Lee Ainslie’s Bio-Techne TECH Stock Holding History

Lee Ainslie’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$108M	Sell	1,535,610 -3,204,111	-68%	-$173M	0.96%	34
2026 Q1	$248M	Buy	4,739,721 +888,798	+23%	+$53.4M	2.86%	12
2025 Q4	$226M	Buy	3,850,923 +838,269	+28%	+$50.9M	2.43%	14
2025 Q3	$168M	Buy	+3,012,654	New	+$161M	2.24%	16
2025 Q2	–	Sell	-522,897	Closed	-$30.7M	–	309
2025 Q1	$30.7M	Buy	+522,897	New	+$35.4M	0.54%	49
2021 Q2	–	Sell	-6,104	Closed	-$583K	–	842
2021 Q1	$583K	Sell	6,104 -2,640	-30%	-$241K	0.01%	370
2020 Q4	$694K	Buy	8,744 +5,916	+209%	+$428K	0.01%	303
2020 Q3	$175K	Buy	2,828 +1,272	+82%	+$82.7K	﹤0.01%	501
2020 Q2	$103K	Sell	1,556 -32,076	-95%	-$1.92M	﹤0.01%	529
2020 Q1	$1.59M	Sell	33,632 -3,284	-9%	-$164K	0.03%	219
2019 Q4	$2.03M	Buy	+36,916	New	+$1.94M	0.03%	265

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lee Ainslie's TECH Position: Q2 2026 in Review

Lee Ainslie reduced its Bio-Techne (TECH) stake by 68% in Q2 2026, selling an estimated $173M and leaving 1,535,610 shares worth $108M. The position accounts for 0.96% of the portfolio, ranked #34.

Lee Ainslie first reported a position in TECH in Q4 2019 and has held it in 11 quarters since. The position peaked at $248M in Q1 2026. 591 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Lee Ainslie held 1,535,610 shares of Bio-Techne worth $108M as of Q2 2026.
Lee Ainslie sold 3,204,111 Bio-Techne shares in Q2 2026, an estimated $173M.
Bio-Techne made up 0.96% of Lee Ainslie's portfolio in Q2 2026, its #34 holding.
Lee Ainslie first reported a position in Bio-Techne in Q4 2019 and has held it in 11 quarters since.
Lee Ainslie's Bio-Techne position peaked at $248M in Q1 2026.
591 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.